Cellink AB (CLNK B):企業の財務・戦略的SWOT分析

◆英語タイトル:Cellink AB (CLNK B) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH3446624FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥43,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Cellink AB (CLNK B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cellink AB (Cellink) develops and commercializes bioprinting technologies which enable researchers to print three dimensional (3D) human organs and tissues. The company’s product portfolio encompasses bioprinters which enable bioprinting of human tissues and tissue models for 3D culture in advanced research; and bioink, a biomaterial innovation that allows researchers to develop and grow 3D human cells to grow as they do in the natural human body environment. Cellink caters to research institutions, pharmaceutical, biopharmaceutical, automotive, and cosmetic companies. The company sells its products through direct sales force in the US and Sweden and through an extensive network of distributors in Europe (excluding Sweden), and Asia-Pacific. It operates a subsidiary in the US. Cellink AB is headquartered in Goteborg, Sweden.

Cellink AB Key Recent Developments

Mar 15,2021: Cellink launches the Bio Mdx Series, a scaled-up revolution in biomedical manufacturing
Mar 11,2021: Cellink announces an offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an expected amount of SEK 2.75 billion
Feb 08,2021: CELLINK announce distribution agreement including new products for Single-Cell RNA Sequencing and NGS Library Preparation
Jan 28,2021: CELLINK announces third year extension of collaboration with a global biopharmaceutical company for drug discovery
Nov 27,2020: CELLINK welcomes new scientific advisor Professor Robert Langer from MIT and co-founder of Moderna

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Cellink AB – Key Facts
Cellink AB – Key Employees
Cellink AB – Key Employee Biographies
Cellink AB – Major Products and Services
Cellink AB – History
Cellink AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Cellink AB – Business Description
R&D Overview
Cellink AB – Corporate Strategy
Cellink AB – SWOT Analysis
SWOT Analysis – Overview
Cellink AB – Strengths
Cellink AB – Weaknesses
Cellink AB – Opportunities
Cellink AB – Threats
Cellink AB – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Cellink AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cellink AB, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cellink AB, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 15, 2021: Cellink launches the Bio Mdx Series, a scaled-up revolution in biomedical manufacturing
Mar 11, 2021: Cellink announces an offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an expected amount of SEK 2.75 billion
Feb 08, 2021: CELLINK announce distribution agreement including new products for Single-Cell RNA Sequencing and NGS Library Preparation
Jan 28, 2021: CELLINK announces third year extension of collaboration with a global biopharmaceutical company for drug discovery
Nov 27, 2020: CELLINK welcomes new scientific advisor Professor Robert Langer from MIT and co-founder of Moderna
Oct 22, 2020: Cellink: Strong organic growth and important strategic acquisition under continued challenging conditions
Oct 21, 2020: CELLINK launches C.WASH, an innovative liquid handling system for automated media change in micro-well plates
Aug 28, 2020: CELLINK welcomes new scientific advisor Professor Ido Amit from the Weizmann Institute of Science
Jul 14, 2020: CELLINK and Kugelmeiers announce strategic partnership for 3D printing cell spheroids
Jul 09, 2020: Cellink – Q3 19/20: Continued growth and main market listing during an ongoing pandemic
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Cellink AB, Key Facts
Cellink AB, Key Employees
Cellink AB, Key Employee Biographies
Cellink AB, Major Products and Services
Cellink AB, History
Cellink AB, Other Locations
Cellink AB, Subsidiaries
Cellink AB, Key Competitors
Cellink AB, Ratios based on current share price
Cellink AB, Annual Ratios
Cellink AB, Annual Ratios (Cont...1)
Cellink AB, Annual Ratios (Cont...2)
Cellink AB, Interim Ratios
Cellink AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Cellink AB, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Cellink AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Cellink AB (CLNK B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • United Spirits Ltd:企業の戦略・SWOT・財務情報
    United Spirits Ltd - Strategy, SWOT and Corporate Finance Report Summary United Spirits Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Legg Mason, Inc.:戦略・SWOT・企業財務分析
    Legg Mason, Inc. - Strategy, SWOT and Corporate Finance Report Summary Legg Mason, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tox Free Solutions Ltd (TOX):企業の財務・戦略的SWOT分析
    Tox Free Solutions Ltd (TOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Tata Consultancy Services Limited:戦略・SWOT・企業財務分析
    Tata Consultancy Services Limited - Strategy, SWOT and Corporate Finance Report Summary Tata Consultancy Services Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Redbiotec AG-製薬・医療分野:企業M&A・提携分析
    Summary Redbiotec AG (Redbiotec) is a biopharmaceutical company that develops prophylactic vaccines, which target various virus associated diseases. The company produces multi component virus like particles and other protein assemblies through its rePAX coexpression technology. It is developing prod …
  • Nine Dragons Paper (Holdings) Ltd:企業の戦略・SWOT・財務分析
    Nine Dragons Paper (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Nine Dragons Paper (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Globavir Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Globavir Biosciences Inc (Globavir) is a biotechnology company that develop combination of drug therapies and diagnostic tests in the therapeutic areas of infection and immune-oncology. The company develops Globavir’s Drug Discovery Platform (GDDP), which generates small molecule candidates …
  • Novo Nordisk A/S:戦略・SWOT・企業財務分析
    Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report Summary Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Total E&P Canada Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Total E&P Canada Ltd (Total E&P Canada), a subsidiary of Total S.A. is an oil and gas company that offers exploration and production of oil and gas properties. The company has assets in Alberta’s Athabasca Oil Sands region, which include Surmont, Northern Lights, Fort Hills and Joslyn North …
  • Petrol dd Ljubljana (PETG):企業の財務・戦略的SWOT分析
    Petrol dd Ljubljana (PETG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Bashas’ Inc.:企業の戦略・SWOT・財務情報
    Bashas' Inc. - Strategy, SWOT and Corporate Finance Report Summary Bashas' Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Pascal Biosciences Inc (PAS)-製薬・医療分野:企業M&A・提携分析
    Summary Pascal Biosciences Inc (Pascal Biosciences), formerly BioMmune Technologies Inc is a biopharmaceutical company that offers discovery and development of new therapeutics that enable the body’s immune system . The company advances technologies which can control the immune activity and improve …
  • Alion Science and Technology Corporation:企業の戦略・SWOT・財務情報
    Alion Science and Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary Alion Science and Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Mercury NZ Limited:企業の戦略・SWOT・財務分析
    Mercury NZ Limited - Strategy, SWOT and Corporate Finance Report Summary Mercury NZ Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Worldpay Us Inc:企業の戦略・SWOT・財務分析
    Worldpay Us Inc - Strategy, SWOT and Corporate Finance Report Summary Worldpay Us Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Velesto Energy Bhd (UMWOG):企業の財務・戦略的SWOT分析
    Summary Velesto Energy Bhd (Velesto) formerly UMW Oil & Gas Corp Bhd, is an oilfield service provider. It serves customers in upstream sector of the oil and gas industry. The company owns and operates offshore drilling rigs and modular and versatile workover units. Its oilfield service offerings inc …
  • T&D Holdings, Inc.:企業の戦略・SWOT・財務分析
    T&D Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary T&D Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • TechnipFMC Plc (FTI):企業の財務・戦略的SWOT分析
    TechnipFMC Plc (FTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Maritz Holdings Inc.:企業の戦略的SWOT分析
    Maritz Holdings Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Kuros Biosciences Ltd (KURN)-製薬・医療分野:企業M&A・提携分析
    Summary Kuros Biosciences Ltd (Kuros Biosciences) is a biotechnology company that develops products for tissue repair and regeneration. It develops a family of bone healing products to address indications in trauma and spine called orthobiologics. It is focused on bone repair for trauma, specificall …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆